Casey Fisher, DO
Otolaryngology · Golden Valley, MNNPI 1669897500
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,293 of the $2,836 with a category attached, or 80.8%. 12 manufacturers reported payments, led by Acclarent, Inc at 37.3% of the total. Reporting peaked in 2019 at $1,395 and has fallen 79.6% since, to $285 in 2025.
Across 55 payments — averaging $51.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Acclarent, Inc$1K
- Medical Device Business Services, Inc.$543
- Integra Lifesciences Corporation$320
- Intersect ENT, Inc.$226
- Stryker$199
- Medtronic$199
- plus $291 from 6 others
What the payments were for
- Travel & lodging$54319%
- Food & beverage$2,29381%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Acclarent, Inc | 28 | $1,058 |
| Medical Device Business Services, Inc. | 1 | $543 |
| Integra Lifesciences Corporation | 3 | $320 |
| Intersect ENT, Inc. | 3 | $226 |
| Stryker | 4 | $199 |
| Medtronic | 4 | $199 |
| Smith+Nephew | 5 | $174 |
| Sanofi | 3 | $48 |
| Cochlear Americas | 1 | $24 |
| Amgen | 1 | $17 |
| AstraZeneca | 1 | $15 |
| Johnson & Johnson | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,836 in reported general payments places this provider in the 80th percentile of 181 otolaryngology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 200 | $4,865 |
| Fluocinolone Acetonide Oil | 56 | $1,811 |
| Ofloxacin | 30 | $754 |
| Mupirocin | 82 | $583 |
| Omeprazole | 41 | $499 |
| Methylprednisolone | 74 | $499 |
| Azelastine Hcl | 13 | $432 |
| Fluticasone Propionate | 34 | $386 |
| Doxycycline Monohydrate | 19 | $223 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 25 | $215 |
| Famotidine | 12 | $211 |
| Cephalexin | 35 | $138 |
| Triamcinolone Acetonide | 14 | $128 |
| Prednisone | 33 | $91 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 24 | $69 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Golden Valley
- Joseph RohrerGolden Valley$2K
- Samuel LevineMinneapolis$151K
- George GodingMinneapolis$143K
- Theodore TruittSaint Cloud$96K
- Matthew CarlsonRochester$80K
- Troy HemmeMaple Grove$28K
- Michael PaparellaMinneapolis$22K
- Oleg FroymovichMinneapolis$20K
- David HamlarSt. Paul$19K
- Rijul KshirsagarRochester$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.